Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
ESSA Pharma Inc. (EPIX) had Income from Continuous Operations of $-26.58M for the most recently reported fiscal year, ending 2023-09-30.
| Income Statement Financials | |
-- |
|
$-26.58M |
|
-- |
|
-- |
|
$32.14M |
|
$-32.14M |
|
$5.56M |
|
$-26.58M |
|
$-26.58M |
|
$-26.58M |
|
|
Income from Continuous Operations |
$-26.58M |
$-26.58M |
|
$-26.58M |
|
$-32.14M |
|
$-32.02M |
|
44.09M |
|
44.09M |
|
$-0.60 |
|
$-0.60 |
|
| Balance Sheet Financials | |
$148.80M |
|
-- |
|
$0.33M |
|
$149.12M |
|
$3.50M |
|
-- |
|
-- |
|
$3.50M |
|
$145.63M |
|
$145.63M |
|
$145.63M |
|
44.10M |
|
| Cash Flow Statement Financials | |
$-19.78M |
|
$-3.53M |
|
$-0.07M |
|
$57.08M |
|
$33.70M |
|
$-23.37M |
|
$5.01M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
42.57 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-19.78M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-18.25% |
|
-18.25% |
|
-17.83% |
|
-18.25% |
|
$3.30 |
|
$-0.45 |
|
$-0.45 |
|